[New sulfonamide-trimethoprim combination, Supristol. Results of a joint therapeutic trial (author's transl)]. 1977

H Frank, and H Jurisch, and H J Kabelitz, and H Staudacher, and S Stoll, and J D Summa, and A Wagner

The efficacy of a new low dosage trimethoprim-sulfamoxole combination (Supristol) was tested in a joint therapeutic study in 6 medical clinics or departments and in a general practice. A good therapeutic result (healing) was achieved in about 80% of the 143 patients included in the trial. The preparation was well tolerated. Symptoms of intolerance appeared in only 2% of the cases. It is assumed that the low dosage of the preparation influences the tolerance favorably without affecting the efficacy.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D001799 Blood Sedimentation Measurement of rate of settling of ERYTHROCYTES in blood. Erythrocyte Sedimentation,Erythrocyte Sedimentation Rate,Erythrocyte Sedimentation Rates,Rate, Erythrocyte Sedimentation,Rates, Erythrocyte Sedimentation,Sedimentation Rate, Erythrocyte,Sedimentation Rates, Erythrocyte,Sedimentation, Blood,Sedimentation, Erythrocyte
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug

Related Publications

H Frank, and H Jurisch, and H J Kabelitz, and H Staudacher, and S Stoll, and J D Summa, and A Wagner
June 1970, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete,
H Frank, and H Jurisch, and H J Kabelitz, and H Staudacher, and S Stoll, and J D Summa, and A Wagner
April 1976, Arzneimittel-Forschung,
H Frank, and H Jurisch, and H J Kabelitz, and H Staudacher, and S Stoll, and J D Summa, and A Wagner
May 1976, Comprehensive therapy,
H Frank, and H Jurisch, and H J Kabelitz, and H Staudacher, and S Stoll, and J D Summa, and A Wagner
May 1976, DTW. Deutsche tierarztliche Wochenschrift,
H Frank, and H Jurisch, and H J Kabelitz, and H Staudacher, and S Stoll, and J D Summa, and A Wagner
January 1976, Arzneimittel-Forschung,
H Frank, and H Jurisch, and H J Kabelitz, and H Staudacher, and S Stoll, and J D Summa, and A Wagner
March 1977, MMW, Munchener medizinische Wochenschrift,
H Frank, and H Jurisch, and H J Kabelitz, and H Staudacher, and S Stoll, and J D Summa, and A Wagner
January 1976, Arzneimittel-Forschung,
H Frank, and H Jurisch, and H J Kabelitz, and H Staudacher, and S Stoll, and J D Summa, and A Wagner
November 1956, Wiener medizinische Wochenschrift (1946),
H Frank, and H Jurisch, and H J Kabelitz, and H Staudacher, and S Stoll, and J D Summa, and A Wagner
January 1975, Nihon Koku Geka Gakkai zasshi,
H Frank, and H Jurisch, and H J Kabelitz, and H Staudacher, and S Stoll, and J D Summa, and A Wagner
January 1976, Arzneimittel-Forschung,
Copied contents to your clipboard!